Monthly Archives: October 2016

Global Private LTE Network Ecosystem Investments To Surpass US$800 Million By The End Of 2016

MarketResearchReports.biz has announced addition of new report “The Private LTE Network Ecosystem: 2016 – 2030 – Opportunities, Challenges, Strategies, Industry Verticals & Forecasts” to its database.

Albany, United States – October 27, 2016 /MarketersMedia/ —

With private LTE networks filling the gap associated with the limited bandwidth of narrowband land mobile radio and security concerns of commercial LTE networks, the global private LTE network ecosystem currently faces high-value opportunities. This is the key conclusion of a new report added to the database of MarketResearchReports.biz. The report is titled, ‘The Private LTE Network Ecosystem: 2016 – 2030 – Opportunities, Challenges, Strategies, Industry Verticals & Forecasts.’ According to the report, global investments in the private LTE network ecosystem will surpass US$800 million by the end of 2016. Between 2016 and 2020 alone, the private LTE networks market is expected to log a strong CAGR of 32%, the report’s findings show.

Much of the growth that lies ahead for the global private LTE network ecosystem market will be brought about by widespread rollouts in sectors such as energy and public safety, the report states. The trend of choosing private LTE networks to deliver mobile broadband is increasingly catching on, and will act as a high-impact growth driver for the market, the report further states. The 370-page report, which studies three submarkets, six regional markets, and five vertical markets, presents a forecast for investments in private LTE networks from 2016 through 2030.

From the standpoint of leading regions, the private LTE network ecosystem market is projected to witness robust growth in North America – the region will attract nearly 35% of all investments made in the world by 2020. Asia Pacific will also be an important market for companies targeting wider geographical growth. In APAC, South Korea’s investments in LTE networks catering to the critical communications needs in railway, public safety, and maritime security will have an evidently positive impact on the growth of the market.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/804866

Companies vying to secure a steady area of growth in the private LTE network ecosystem market have rolled out exclusive mobile broadband services for energy sector players. Examples of such companies include Texas Energy Network and Infrastructure Networks. However, since investments in private LTE networks can be prohibitively expensive, European countries are using private mobile core platforms in conjunction with LTE networks to allow public safety organizations to subscribe to prioritized mobile broadband services.

The competitive landscape is also seeing a change with new partnerships being forged between conventional LMR industry players and established LTE infrastructure OEMs. Examples of the latter include Nokia, Ericsson, and Samsung; these companies are tapping into this emerging opportunity by offering end-to-end solutions for private LTE networks.

Numerous companies have been profiled in the report to assess their strategic moves, revenue growth, and presence across the entire ecosystem. Likewise, the report also studies the opportunity that lies in the private LTE network ecosystem in every key country. By doing so, the report serves as a tool to give vendors and systems integrators in the private LTE network ecosystem insights into remaining relevant and competitive.

For more information, please visit http://www.marketresearchreports.biz/pressrelease/2392

Contact Info:
Name: Rohit Bhisey
Organization: MarketResearchReports.biz
Address: State Tower 90 State Street, Suite 700 Albany, NY 12207 United States
Phone: +1-518-621-2074

Source: http://marketersmedia.com/global-private-lte-network-ecosystem-investments-to-surpass-us800-million-by-the-end-of-2016/141627

Release ID: 141627

Thunder Mountain Gold Appoints Mr. James A. Sabala to its Board

BOISE, ID / ACCESSWIRE / October 27, 2016 / Thunder Mountain Gold, Inc. (the “Company” or “Thunder Mountain”) (TSX-V: THM; OTCQB: THMG) is pleased to announce that the Board of Directors has appointed James A. Sabala as a Director of Thunder Mountain Gold, replacing Mr. Ed Fields who will step aside and serve the Board as Technical Advisor.

Ralph Noyes, former Vice President of Metal Mining – Hecla Mining Company, and fellow Board Member commented, “I had the pleasure of working opposite Jim during his tenure at Coeur Mining and Stillwater Mining Company, negotiating several transactions with his company. Besides his competence in the financial markets, and concentrate marketing, Jim understands the technology and psychology of underground mining. I look forward to our continuing association.”

Mr. Sabala graduated from the University of Idaho with a B.S. Business, Summa Cum Laude in 1978, and currently resides near Coeur d`Alene, Idaho.

Prior to his retirement in May, 2016, Mr. Sabala was Senior Vice President and Chief Financial Officer of Hecla Mining Company, a silver, gold, lead and zinc mining company with operations throughout North America and Mexico. Mr. Sabala was appointed Chief Financial Officer in May 2008 and Senior Vice President in March 2008. Prior to his employment with Hecla Mining Company, Mr. Sabala was Executive Vice President – Chief Financial Officer of Coeur Mining from 2003 to February 2008. Mr. Sabala also served as Vice President-Chief Financial Officer of Stillwater Mining Company from 1998 to 2002. Mr. Sabala has served as a director of Arch Coal (NYSE: ACI) since February, 2015 and currently serves as a director of Dolly Varden Silver (TSX-V: DV).

Jim Collord, Vice President, Chief Operating Officer, and founding member of the Company with Board service of more than 38 years added, “I am very excited to see the positive evolution of Thunder Mountain with the addition Jim Sabala. The makeup of the Board will be able to direct the Company into the future. At the same time, we greatly appreciate the time and expertise that Ed Fields has brought to the Board, and we look forward to his continued service as Technical Advisor.”

Thunder Mountain Gold, Inc, is a U.S. – based exploration company founded in 1935, has assembled a top tier Board and Management team, with direct ownership interest in two U.S. precious and base metal projects. The Company’s principal asset is The South Mountain Project – a former producer of zinc-silver-gold project with copper and lead, located in southern Idaho’s Owyhee County. The Company’s Trout Creek Project is a grass roots gold target, drill ready, and located in the Eureka-Battle Mountain trend of central Nevada. For more information on Thunder Mountain Gold, please visit the Company’s website at Thundermountaingold.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on the beliefs of management and reflect the Company’s current expectations. The forward-looking statements are based on certain assumptions, which could change materially in the future. By their nature, forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, investors should not place undue reliance on forward-looking information. Forward-looking information is provided as of the date of this press release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances, except as required in accordance with applicable laws.

Cautionary Note to Investors

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The United States Securities and Exchange Commission (“SEC”) permits mining companies, in their filings with the SEC, to disclose only those mineral deposits that a company can economically and legally extract or produce.

For further information, please contact:

Thunder Mountain Gold, Inc.

Eric Jones
President and Chief Executive Officer
eric@thundermountaingold.com
Tel: (208) 658-1037

Jim Collord
Chief Operating Officer
jim@thundermountaingold.com
Tel: (208) 658-1037

SOURCE: Thunder Mountain Gold, Inc.

ReleaseID: 447821

Global Rehabilitation Robots Market Size, Shares, Strategies, Opportunities and Forecasts 2016-2022

ResearchMoz added Latest Research Report titled ” Rehabilitation Robots Market 2016-2022: Worldwide Market Size, Shares, Trends, Growth, Survey and Forecast report ” to it’s Large Report database.

Albany, United States – October 27, 2016 /MarketersMedia/ —

The 2016 study has 774 pages, 296 tables and figures. Worldwide markets are poised to achieve significant growth as the rehabilitation robots, active prostheses, and exoskeletons are used inside rehabilitation treatment centers and sports facilities providing rehabilitation for all patients with injuries or physical dysfunction.

Research has found that by actively engaging stroke patients in repetitive tasks, the brain is able to rewire neurological pathways to motor functions. In this manner patients who have lost functions are able to relearn movement. The awareness and movement of hemi-paretic limbs can occur and functional recovery can continue even years after the brain injury. Much of the damage to a brain comes from lack of oxygen, even brief lack of oxygen is detrimental to the brain. The ability to recover is an ongoing process, something that robotic therapy over time will help.

Now, the reimbursement times for physical therapy are limited, and clinicians tell patients that everything that can be done has been done after a relatively short time. Robotic rehabilitation can continue after services are no longer paid for, giving people longer recovery times and more hope to regain lost function.

Robotic rehabilitation devices are based on automated process, use of a motor or use of microprocessor technology controlled by software. Rehabilitation robot vendors have set out to create repetitive process that works to help people improve their physical wellbeing using a robot, to improve more than they would without the robot. Improvements come because of a reduction in the cost of care delivery, making the rehabilitation more affordable and therefore able to be continued longer, or because of a reduction in boredom.

Get a Sample Research PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=716067

Lack of knowledge about what protocols would work for a particular patient in a particular situation contributes to lack of rehabilitation benefit and patients stuck without optimum movement. Rehabilitation robots can be customized to create automated process that is responsive to patient needs.

Robotic rehabilitation devices use automated process to motivate patients and help them to improve their motor abilities. Motors are used to drive continuous motion machines to build muscle tone. Advances in robotics and bionics help therapists diagnose more precisely, increase clinic efficiencies, and reach more patients. Robotic physical therapy technologies improve patient engagement and HEP compliance. All better patient experience in turn leads to improved outcomes.

The rehabilitation robots can show patients progress and keep the progress occurring, encouraging patients to work on getting healthier. Independent functioning of patients depends on intensity of treatment, task-specific exercises, active initiation of movements and motivation and feedback. Rehabilitation robots can assist with these tasks in multiple ways. Creating a gaming aspect to the rehabilitation process has brought a significant improvement in systems.

As patients get stronger and more coordinated, a therapist can program the robot to let them bear more weight and move more freely in different directions, walking, kicking a ball, or even lunging to the side to catch one. The robot can follow the patient’s lead as effortlessly as a ballroom dancer, its presence nearly undetectable until it senses the patient starting to drop and quickly stops a fall. In the later stages of physical therapy, the robot can nudge patients off balance to help them learn to recover.

Rehabilitation robot market size at $221.4 million in 2015 is expected grow dramatically to reach $1.1 billion by 2022. Exoskeleton markets will be separate and additive to this market. A separate exoskeleton market will create more growth. Market growth is a result of the effectiveness of robotic treatment of muscle difficulty. The usefulness of the rehabilitation robots is increasing. Doing more sophisticated combinations of exercise have become more feasible as the technology evolves. Patients generally practice 1,000 varied movements per session. With the robots, more sessions are possible.

Enquiry at: http://www.researchmoz.us/enquiry.php?type=E&repid=716067

Market Leaders
– AlterG
– Myomo
– InMotion Robots
– Hocoma
– Ekso Bionics
– Patterson
– Chatanoonga
– BioNik / Interactive Motion Technologies

For more information, please visit http://www.researchmoz.us/rehabilitation-robots-market-shares-strategies-and-forecasts-worldwide-2016-to-2022-report.html

Contact Info:
Name: Rohit Bhisey
Organization: Researchmoz Global Pvt. Ltd.
Address: 90 State Street, Albany, NY 12207
Phone: +1-518-621-2074

Source: http://marketersmedia.com/global-rehabilitation-robots-market-size-shares-strategies-opportunities-and-forecasts-2016-2022/141669

Release ID: 141669

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Wells Fargo & Company (WFC) & Lead Plaintiff Deadline – November 25, 2016

NEW YORK, NY / ACCESSWIRE / October 27, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Wells Fargo & Company (“Wells Fargo” or the “Company”) (NYSE: WFC) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased Wells Fargo securities between February 26, 2014 and September 15, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that Wells Fargo’s cross-selling efforts to retail customers was part of a carefully designed plan to illegally open millions of deposit and credit card accounts for customers without their knowledge or consent, in an effort to generate fee income for Wells Fargo and compensation rewards for defendants.

Wells Fargo also failed to disclose that the continuing internal investigation had determined by the beginning of the Class Period that employees in the Community Banking division were engaged in a mass scheme to expand Wells Fargo’s financial performance figures by opening millions of unauthorized deposit and credit card accounts, resulting in over 5,000 employee terminations. Consequently, defendants’ statements about Wells Fargo’s
business, operations, and prospects were false and misleading and/or lacked a reasonable basis as Wells Fargo stock traded at artificially inflated prices, at a high of over $58 per share, which allowed some defendants to sell more than $31 million worth of their own Wells Fargo stock at artificially inflated prices.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/wfc or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Wells Fargo you have until November 25, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 446099

SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016

NEW YORK, NY / ACCESSWIRE / October 27, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased Spectrum securities between December 16, 2015 through September 16, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Food and Drug Administration (the “FDA”) previously questioned whether the data from the 611 and 612 Studies were clinically significant; (2) the FDA instructed defendants in December 2012 not to submit the New Drug Application based on data from the 611 and 612 Studies; and (3) consequently, defendants’ public statements regarding the Company’s business, operations and prospects were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/sppi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Spectrum you have until November 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 445845

SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Misonix, Inc. (MSON) and Lead Plaintiff Deadline – November 18, 2016

NEW YORK, NY / ACCESSWIRE / October 27, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Misonix, Inc. (“Misonix” or the “Company”) (NASDAQ: MSON) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased Misonix securities between November 5, 2015 through September 14, 2016, both dates inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

On September 14, 2016, Misonix revealed that it will delay its Annual Report filing on Form 10-K for the fiscal year ended June 30, 2016 due to the pending investigation by Misonix’s Audit Committee in connection to its defects in internal control over financial reporting at June 30, 2016. Following this news, Misonix stock dropped during intraday trading on September 15, 2016.

According to the Complaint, Defendants made false and/or misleading statements and/or failed to disclose that: (1) insufficiencies existed in Misonix’s internal controls over financial reporting; and (2) consequently, Defendants’ statements about Misonix’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/mson or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Misonix you have until November 18, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 445675

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Twitter, Inc. (TWTR) and Lead Plaintiff Deadline – November 15, 2016

NEW YORK, NY / ACCESSWIRE / October 27, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court, Northern District of California on behalf of those who purchased shares of Twitter, Inc. (“Twitter” or the “Company”) (NYSE: TWTR) between February 6, 2015 and July 28, 2015 both dates inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

Twitter is an online global social networking service that enables users to send and read short 140-character messages called “tweets”. Twitter’s main source of revenue is advertising. Advertising income is driven by the number of users the level of engagement of such users.

The complaint alleges that during the Class Period, the Company made materially false and/or misleading statements and/or failed to disclose: (1) that by early 2015, Twitter’s daily active users (DAUs) had switched the timeline views metric as the main user engagement metric which is tracked internally by
Twitter management; (2) that the trend in user engagement growth was lessening; (3) that new product initiatives were not having a significant impact on
monthly active users (MAUs) or user engagement; (4) that Twitter stated “acceleration” was the result of low-quality monthly active user growth; (5) and
that Twitter lacked a basis for its previously disclosed estimates of about 20% MAU growth and 550 million MAU in the immediate term.

On April 28, 2015, Twitter announced its first quarter 2015 financial results and its projections for the second quarter of 2015, with an estimated second quarter revenue between $470 million to $485 million. Twitter also reduced its full year 2015 revenue forecast from a previous guidance of $2.30 billion to $2.35 billion to $2.17 billion and $2.27 billion. Following this news, Twitter stock dropped $9.39 per share, or 18.18%, to close at $42.27 on April 28, 2015. Later, on July 28, 2015, post-market, Twitter announced its second quarter 2015 financial results and projections for the third quarter of 2015, estimating revenue between $545 million to $560 million. Twitter also projecting revenue for 2015 full year in the range of $2.20 billion to $2.27 billion. Following this news, Twitter stock dropped $5.30 per share, or 14.51%, close at $31.24 on July 29, 2015

No Class has yet been certified in the above action. To discuss this action, or for any questions, please visit the firm’s site:
http://www.bgandg.com/twtr or contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Twitter, you have until November 15, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 445526

Burn Care Market worth 2.33 Billion USD by 2021

he global burn care market is expected to reach USD 2.33 Billion by 2021 from USD 1.68 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021.

Seattle, USA – October 27, 2016 /MarketersMedia/ —

The report “Burn Care Market by Product (Advanced (Alginate, Collagen, Hydrocolloid, Hydrogel), Biologics, Traditional), Depth (Minor, Partial-thickness, Full-thickness Burn), End-Users (Hospitals (Inpatient, Outpatient), Physician Clinics, Homecare) – Forecast to 2021”.

Browse 140 market data Tables and 107 Figures spread through 187 Pages and in-depth TOC on “Burn Care Market”
http://www.marketsandmarkets.com/Market-Reports/burn-care-market-247121470.html
Early buyers will receive 10% customization on reports.

Market growth can be attributed to factors such as rising incidence of burns, increasing healthcare expenditure, favorable government initiatives, increasing number of emergency centers and burn units, and growing awareness regarding treatment options.

In this report, the burn care market has been segmented on the basis of product, depth of burn, end user, and region. Based on product, the market is segmented into advanced burn care, biologics, traditional burn care, and other burn care products. The advanced burn care products segment includes alginate dressings, collagen dressings, hydrogel dressings, hydrocolloid dressings, wound contact layers, film dressings, and foam dressings. Among these, the advanced burn care products segment is expected to account for the largest share of the market in 2016; while, the biologics segment is projected to witness the highest CAGR from 2016 to 2021.

Based on the depth of burn, the burn care market is segmented into minor, partial-thickness, and full-thickness burns. The partial-thickness burns segment is expected to account for the largest share in 2016, owing to the increasing usage of advanced dressings and biologics such as skin grafts and substitutes.

On the basis of end users, the burn care market is segmented into hospitals, physician clinics, home care and other end users. The hospitals segment is expected to account for the largest share of the global burn care market in 2016. The rise in healthcare spending and government initiatives have increased the use of burn care products in hospitals.

Based on regions, the burn care market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Factors such as increasing demand for biologics like skin grafts and its substitutes and high usage of advanced dressings in the U.S. are driving growth in the North American burn care market.

Key players in the Burn Care Market include:

Smith & Nephew plc (U.K.)
Mölnlycke Health Care (Sweden)
Convatec Inc. (U.K.)
Acelity L.P. (U.S.)
Coloplast A/S (Denmark)
Derma Sciences, Inc. (U.S.)
Medtronic (Ireland)

For more information, please visit http://www.marketsandmarkets.com/requestsample.asp?id=247121470

Contact Info:
Name: Rohan
Organization: MarketsandMarkets

Source: http://marketersmedia.com/burn-care-market-worth-2-33-billion-usd-by-2021/141206

Release ID: 141206

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MoneyGram International Inc. (MGI) and Lead Plaintiff Deadline-November 14, 2016

NEW YORK, NY / ACCESSWIRE / October 27, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court for the District of Delaware on behalf of those who purchased shares of MoneyGram International Inc. (“MoneyGram” or the “Company”) (NASDAQ: MGI) pursuant and/or traceable to the secondary public offering completed on or around April 2, 2014 (the “Offering”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that MoneyGram allegedly made false and misleading statements and omissions regarding Walmart’s possible entry into the money transfer business and the likely effect it would have on the Company. On April 17, 2014, two weeks after the Offering, Walmart publicized that it was initiating its own money transfer service on April 24, 2014. Following this news, MoneyGram’s stock dropped close to 30%.

No Class has yet been certified in the above action. To discuss this action, or for any questions, please visit the firm’s site: http://www.bgandg.com/mgi. or contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in MoneyGram, you have until November 14, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 445576

SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MGT Capital Investments, Inc. (MGT) & Lead Plaintiff Deadline: November 21, 2016

NEW YORK, NY / ACCESSWIRE / October 27, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against MGT Capital Investments, Inc. (“MGT” or the “Company”) (NYSE MKT: MGT) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased MGT securities between May 9, 2016 and September 20, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

MGT acquires, advances, and monetizes assets in the online, mobile, and casino gaming space. The Company operates through two segments, Gaming and Intellectual Property. The Company is currently in the process of acquiring D-Vasive, a provider of leading edge anti-spy software, and Demonsaw, a provider of a secure and anonymous file sharing software platform.

On May 9, 2016, MGT announced that it had entered into an agreement to acquire certain assets and technologies from D-Vasive Inc. (“D-Vasive”), a provider of anti-spy software (the “D-Vasive Transaction”). With this acquisition, MGT announced the planned position of Defendant John McAfee (“McAfee”) as MGT’s Executive Chairman and Chief Executive Officer (“CEO”), and the planned corporate name change to John McAfee Global Technologies, Inc. MGT notified investors that “[m]ajor terms of the deal include the payment to D-Vasive Inc. stockholders of 23.8 million restricted shares of MGT stock and $300,000 in cash. The proposed share issuance is expected to amount to roughly 47% of the Company on a pro-forma diluted basis at closing.”

Then, on May 26, 2016, the Company publicized that it had entered into an agreement to acquire certain technology and assets from Demonsaw LLC (“Demonsaw”), which MGT said is “a provider of a secure and anonymous file sharing software platform.” MGT notified investors that “[m]ajor terms of the deal include the payment to Demonsaw LLC members of 20.0 million restricted shares of MGT common stock. The proposed share issuance is expected to amount to approximately 28% of the Company’s common stock on a pro-forma fully diluted basis at closing, inclusive of shares of common stock to be issued in connection with the Company’s previously announced transaction with D-Vasive, Inc.” MGT and D-Vasive would then arrange for D-Vasive to purchase Demonsaw in advance of the D-Vasive Transaction, “in order to simplify these transactions, and meet certain customary tax issues,” so that MGT would acquire Demonsaw’s assets as well as D-Vasive’s via the D-Vasive Transaction.

On September 9, 2016, at MGT’s 2016 Annual Meeting of Stockholders, the Company stated its the issuance of a total of 43.8 million shares of common stock in connection with the D-Vasive Transaction had been approved by its shareholders.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose: (1) the NYSE was unlikely to approve the listing of the 43.8 million additional shares that MGT was required to issue in connection with the acquisitions of D-Vasive and Demonsaw; and (2) consequently, MGT’s public statements were materially false and misleading at all relevant times.

On September 19, 2016, pre-market, MGT announced that on September 15, 2016, it received a subpoena from the Securities and Exchange Commission (“SEC”). The Company stated that it does not believe it will be the subject of any enforcement proceedings and is fully cooperating with the SEC’s requests. Following this news, MGT stock dropped $0.74 per share, or 22.7%, to close at $2.52 on September 19, 2016.

Then on September 20, 2016, MGT announced that the NYSE had informed MGT on September 19, 2016 that it would “not approve the listing on the Exchange of the 43.8 million shares that the Company is required to issue in order to complete the closing of the D-Vasive [sic] merger,” and that “[t]he Company and John McAfee remain committed to closing the transaction and are exploring alternatives.”

Then on September 20, 2016, MGT announced that the NYSE would not approve the listing of 43.8 million shares.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/mgt or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in MGT you have until November 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 446007